An experimental study on the ameliorating effect of terazosin on whole‐brain irradiation‐induced cognitive dysfunction
Ma Jiayan1, Zhu Xueting2, Yang Hongying3, Zhang Liyuan4
1Department of Experimental Center, Second Affiliated Hospital of Soochow University, Suzhou 215004, China; 2Department of Radiotherapy and Oncology, Affiliated People's Hospital of Jiangsu University, Zhenjiang 212002, China; 3School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China; 4Department of Radiotherapy and Oncology, Laboratory for Combined Radiotherapy and Immunotherapy of Cancer, Second Affiliated Hospital of Soochow University/Suzhou Key Laboratory for Combined Radiotherapy and Immunotherapy of Cancer, Suzhou 215004, China
Abstract:Objective To verify the protective effect of terazosin on cognitive function of rats after whole-brain irradiation (WBI) and to investigate its mechanism. Methods A total of 64 1-month-old male SD rats were randomly divided into the untreated control group, terazosin group, irradiation group and irradiation plus terazosin group (combination group). WBI was administered at a single dose of 20 Gy in the irradiation and combination groups. The open field test and the Morris water maze (MWM) test were used to evaluate the effect of terazosin on cognitive function after WBI.Starting from the three aspects of juvenile neuron apoptosis, neurogenesis disorderand microglia activation, the possible cellular mechanism wasassayed by double-label immunofluorescence staining for BrdU (bromodeoxyuridine) / NeuN, DCX(Doublecortin) / Caspase-3 and single-label immunofluorescence staining for Iba-1 (ionized calcium binding adaptor molecule-1). Results Terazosin intervention improved the short-term memory retention of irradiated rats (P=0.032). After terazosin treatment, the number of DCX+ cells in the combination groupwas increased by approximately 35% compared with that in the irradiation group (P=0.038). The number of BrdU+/NeuN+ cells in the combination group was increased by approximately 15% than that in the irradiation group (P>0.05). The number of Iba-1+ cells in the irradiation plus terazosin group was decreased by 49% compared with that in the irradiation group (P=0.036). Conclusion Terazosin may reduce the hippocampal juvenile neuron loss and inhibit neuroinflammation via microglia activation, which can alleviate WBI-induced cognitive dysfunction to a certain extent.
Ma Jiayan,Zhu Xueting,Yang Hongying et al. An experimental study on the ameliorating effect of terazosin on whole‐brain irradiation‐induced cognitive dysfunction[J]. Chinese Journal of Radiation Oncology, 2022, 31(11): 1034-1038.
[1] Haldbo-Classen L, Amidi A, Lukacova S, et al.Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours[J]. Radiother Oncol, 2020,148:1-7. DOI: 10.1016/j.radonc.2020.03.023. [2] Turnquist C, Harris BT, Harris CC. Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation[J]. Neurooncol Adv, 2020,2(1):vdaa057. DOI: 10.1093/noajnl/vdaa057. [3] Liu M, Yuan H, Yin J, et al.Effect of hydrogen-rich water on radiation-induced cognitive dysfunction in rats[J]. Radiat Res, 2020,193(1):16-23. DOI: 10.1667/RR15464.1. [4] Lange M, Joly F, Vardy J, et al.Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors[J]. Ann Oncol, 2019,30(12):1925-1940. DOI: 10.1093/annonc/mdz410. [5] Farshi A, DalirAkbari N, Zomorrodi A, et al. A randomized crossover pilot study examining the effect of carvedilol and terazosin plus enalapril on urinary symptoms of patients with hypertension and benign prostatic hyperplasia[J]. Urol J, 2021,18(3):337-342. DOI: 10.22037/uj.v18i.5678. [6] Mathur RP, Nayak S, Sivaramakrishnan R, et al.Role of alpha blockers in hypertension with benign prostatic hyperplasia[J]. J Assoc Physicians India, 2014,62(9 Suppl):40-44. [7] Foltynie T.Glycolysis as a therapeutic target for Parkinson's disease[J]. Lancet Neurol, 2019,18(12):1072-1074. DOI: 10.1016/S1474-4422(19)30404-1. [8] Zhang LY, Chen LS, Sun R, et al.Effects of expression level of DNA repair-related genes involved in the NHEJ pathway on radiation-induced cognitive impairment[J]. J Radiat Res, 2013,54(2):235-242. DOI: 10.1093/jrr/rrs095. [9] Zhang L, Li K, Sun R, et al.Minocycline ameliorates cognitive impairment induced by whole-brain irradiation: an animal study[J]. Radiat Oncol, 2014,9:281. DOI: 10.1186/s13014-014- 0281-8. [10] Zhao J, Bi W, Xiao S, et al.Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice[J]. Sci Rep, 2019,9(1):5790. DOI: 10.1038/s41598-019-42286-8. [11] Kang J, Kim W, Seo H, et al.Radiation-induced overexpression of transthyretin inhibits retinol-mediated hippocampal neurogenesis[J]. Sci Rep, 2018,8(1):8394. DOI: 10.1038/s41598-018-26762-1. [12] Kim CH, Ko IG, Kim SE, et al.Alpha1-adrenoceptor antagonists improve memory by activating n-methyl -d-aspartate-induced ion currents in the rat hippocampus[J]. Int Neurourol J, 2015,19(4):228-236. DOI: 10.5213/inj.2015.19.4.228. [13] Cai R, Zhang Y, Simmering JE, et al.Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases[J]. J Clin Invest, 2019,129(10):4539-4549. DOI: 10.1172/JCI129987. [14] Karschnia P, Parsons MW, Dietrich J.Pharmacologic management of cognitive impairment induced by cancer therapy[J]. Lancet Oncol, 2019,20(2):e92-e102. DOI: 10.1016/S1470-2045(18)30938-0. [15] Chen X, Zhao C, Li X, et al.Terazosin activates Pgk1 and Hsp90 to promote stress resistance[J]. Nat Chem Biol, 2015,11(1):19-25. DOI: 10.1038/nchembio.1657. [16] Ji S, Wu H, Ding X, et al.Increased hippocampal TrkA expression ameliorates cranial radiation‑induced neurogenesis impairment and cognitive deficit via PI3K/AKT signaling[J]. Oncol Rep, 2020,44(6):2527-2536. DOI: 10.3892/or.2020.7782. [17] Conner KR, Forbes ME, Lee WH, et al.AT1 receptor antagonism does not influence early radiation-induced changes in microglial activation or neurogenesis in the normal rat brain[J]. Radiat Res, 2011,176(1):71-83. DOI: 10.1667/rr2560.1. [18] Makale MT, McDonald CR, Hattangadi-Gluth JA, et al. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours[J]. Nat Rev Neurol, 2017,13(1):52-64. DOI: 10.1038/nrneurol.2016.185. [19] Iadecola C, Gottesman RF.Neurovascular and cognitive dysfunction in hypertension[J]. Circ Res, 2019,124(7):1025-1044. DOI: 10.1161/CIRCRESAHA.118.313260. [20] Wang CH, Li SH, Weisel RD, et al.C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle[J]. Circulation, 2003,107(13):1783-1790. DOI: 10.1161/01.CIR.0000061916.95736.E5. [21] Escobales N, Crespo MJ.Oxidative-nitrosative stress in hypertension[J]. Curr Vasc Pharmacol, 2005,3(3):231-246. DOI: 10.2174/1570161054368643. [22] Ungvari Z, Csiszar A, Kaminski PM, et al.Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system[J]. Am J Pathol, 2004,165(1):219-226. DOI: 10.1016/S0002-9440(10)63290-7. [23] Ungvari Z, Csiszar A, Huang A, et al.High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase[J]. Circulation, 2003,108(10):1253-1258. DOI: 10.1161/01.CIR.0000079165. 84309.4D.